BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38821881)

  • 1. Methotrexate for the neurologist.
    Jesuthasan A; Baheerathan A; Auger S; Dorsey R; Coker R; Selvapatt N; Viegas S
    Pract Neurol; 2024 May; ():. PubMed ID: 38821881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate in Crohn's disease: a new face for an old drug?
    Cesarini M; Festa S; Papi C
    Expert Rev Gastroenterol Hepatol; 2016 Oct; 10(10):1135-1144. PubMed ID: 27148828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.
    Herfarth HH; Kappelman MD; Long MD; Isaacs KL
    Inflamm Bowel Dis; 2016 Jan; 22(1):224-33. PubMed ID: 26457382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy.
    Cervoni JP; Alby-Lepresle B; Weil D; Zhong P; Aubin F; Wendling D; Toussirot E; Vuitton L; Carbonnel F; Blondet R; Thévenot T; Calès P; Monnet E; Di Martino V
    Clin Res Hepatol Gastroenterol; 2020; 44S():100003. PubMed ID: 33602481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with the use of low-dose methotrexate for inflammatory bowel disease.
    Soon SY; Ansari A; Yaneza M; Raoof S; Hirst J; Sanderson JD
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):921-6. PubMed ID: 15316419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis.
    van de Meeberg MM; Hebing RCF; Nurmohamed MT; Fidder HH; Heymans MW; Bouma G; de Bruin-Weller MS; Tekstra J; van den Bemt B; de Jonge R; Bulatović Ćalasan M
    Br J Clin Pharmacol; 2023 Jan; 89(1):61-79. PubMed ID: 36326810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Wang Y; Tsoulis DJ; MacDonald JK; Feagan BG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003459. PubMed ID: 25099640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absorption of low-dose methotrexate in patients with inflammatory bowel disease.
    Moshkowitz M; Oren R; Tishler M; Konikoff FM; Graff E; Brill S; Yaron M; Gilat T
    Aliment Pharmacol Ther; 1997 Jun; 11(3):569-73. PubMed ID: 9218084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine and the neurologist.
    McWilliam M; Khan U
    Pract Neurol; 2020 Feb; 20(1):69-74. PubMed ID: 31444234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate in the Treatment of Psoriasis and Rheumatoid Arthritis: Mechanistic Insights, Current Issues and Novel Delivery Approaches.
    Rajitha P; Biswas R; Sabitha M; Jayakumar R
    Curr Pharm Des; 2017; 23(24):3550-3566. PubMed ID: 28571554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V; Wang Y; MacDonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006884. PubMed ID: 25157445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study.
    Ardizzone S; Bollani S; Manzionna G; Imbesi V; Colombo E; Bianchi Porro G
    Dig Liver Dis; 2003 Sep; 35(9):619-27. PubMed ID: 14563183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate and lung disease in rheumatoid arthritis.
    Conway R; Carey JJ
    Panminerva Med; 2017 Mar; 59(1):33-46. PubMed ID: 27711025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate: should we start using it in clinical practice?
    Miheller P; Kiss LS; Mandel M; Lakatos PL
    Curr Drug Targets; 2013 Nov; 14(12):1480-9. PubMed ID: 23651163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.